Pure Global
NCT04280159

Modern Hybrid Imaging in Patients With OSCC

Modern Hybrid Imaging for Staging and Monitoring Patients With Oral Squamous Cell Carcinoma
Wuerzburg University Hospital·ClinicalTrials.govCompleted
View on ClinicalTrials.gov →
Study focus
Disease/Condition
Neoplasm
Study type
Observational
Sponsor & location
Primary sponsor
Wuerzburg University Hospital
Location
Würzburg, Germany
Timeline & enrollment
Phase
N/A
Start date
Jun 28, 2013
End date
Dec 31, 2018
Enrollment
265 participants
Primary outcome

Diagnostic accuracy of FGD-PET/CT to detect the primary tumor,Diagnostic accuracy of FGD-PET/CT to detect lymph nodes metastases,Diagnostic accuracy of FGD-PET/CT to detect distant lymph node metastases.

Summary

Prospective diagnostic study to determine the diagnostic accuracy of preoperative
 18F--fluorodeoxyglucose (FDG) positron emission tomography/computed tomography (PET/CT) in
 detecting local tumor extent, cervical lymph node metastases and distant metastases/secondary
 primary tumor.

ICD-10 classifications
NeoplasmsBenign neoplasmsIn situ neoplasmsPersonal history of other neoplasmsBenign neoplasm: Other specified sites
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT04280159
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for NCT04280159 through Pure Global AI's free database. This phase not specified trial is sponsored by Wuerzburg University Hospital and is currently Completed. The study focuses on Neoplasm. Target enrollment is 265 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.